ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0723

Social Determinants of Health and Time to First Pediatric Rheumatology Appointment in Polyarticular Juvenile Idiopathic Arthritis

Nayimisha Balmuri1, Victoria Cooley2, Linda Gerber2, Susan Goodman3, Bella Mehta3 and Karen Onel4, 1Hospital for Special Surgery, new york, NY, 2Weill Cornell Medicine, NY, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Pediatric Rheumatology, Hospital for Special Surgery, New York, NY

Meeting: ACR Convergence 2020

Keywords: Access to care, Juvenile idiopathic arthritis, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Pediatric Rheumatology – Clinical Poster II: JIA

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with polyarticular JIA (pJIA) have a refractory disease course with increased risk for joint damage resulting in poor functional outcome and decreased quality of life. The highest risk is in patients who are younger at diagnosis. Therefore, it is important for patients to receive timely access to pediatric rheumatology for management. The objective of this study is to examine the association of social determinants of health (SDoH)  on time from reported symptom onset (pain, joint stiffness, swelling) to first appointment with pediatric rheumatology in pJIA patients.

Methods: We retrospectively analyzed Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry from July 2015 through February 2020. Inclusion criteria were USA residency and pJIA diagnosis with recorded >4 joints involved in first 6 months of disease, exclusion criteria were invalid zip code and additional diagnosis of systemic inflammatory or autoimmune disease. The SDoH we studied were family income, guardian’s highest level of education, and community poverty level. Demographics, approximate date of symptom onset, were queried. Five-digit zip-codes were used to extrapolate community poverty levels using 2014-2018 American Community Survey data. The Kaplan-Meier method was used to estimate rheumatology visit-free survival. The log-rank test was used to compare rheumatology visit-free survival between the SDoH. Cox proportional-hazards models were utilized to estimate hazard ratios for the outcome mentioned above, adjusted for age of diagnosis.

Results: 1684 patients fit criteria for this study. Demographics are listed in Table 1. Twenty percent of patients had missing time to first appointment. The median time from symptom onset to first pediatric rheumatology visit was 3 months (IQR: 1,6).  Kaplan-Meier curves showing the probability of first rheumatology visit for time from symptom onset are shown in figure 1. Children with family reported income in the range of $25,000-49,999 were likely to have longer time to first appointment (unadjusted HR 0.76, CI 0.6-0.97, p = 0.025).  These relationships remain consistent when additionally adjusted for age at diagnosis (table 2). Guardian’s highest level of education, and community poverty level did not affect the time to first appointment.

Conclusion: Family reported income, guardian education, and community poverty did not impact time to first appointment. Children within the income bracket of $25,000-49,999 may have less access to subspecialists, transportation, or advocacy compared to other children. Ascertainment bias into the registry may skew the cohort to a wealthy and educated population. Recall bias on symptom onset is possible.  Future directions for research include stratification of community poverty levels and evaluation of public vs private insurance on time to first appointment.

Table1: Patient Characteristics and demographics

Figure 1: Kaplan- Meier curves for time from symptom onset to date first presentation to pediatric rheumatologist

Table 2: Association of social determinants of health with time to first presentation to pediatric rheumatologist


Disclosure: N. Balmuri, None; V. Cooley, None; L. Gerber, None; S. Goodman, Pfizer, 1, Novartis, 1, UCB, 1, regenosine, 1, 2, Horizon, 1; B. Mehta, Novartis, 1; K. Onel, None.

To cite this abstract in AMA style:

Balmuri N, Cooley V, Gerber L, Goodman S, Mehta B, Onel K. Social Determinants of Health and Time to First Pediatric Rheumatology Appointment in Polyarticular Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/social-determinants-of-health-and-time-to-first-pediatric-rheumatology-appointment-in-polyarticular-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/social-determinants-of-health-and-time-to-first-pediatric-rheumatology-appointment-in-polyarticular-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology